Your session is about to expire
← Back to Search
Listening to Women for Depression
Study Summary
This trial will compare the effects of a text-message based mental health screening and intervention program to usual care in pregnant and postpartum women.
- Depression
- Substance Abuse
- Pregnancy
- Anxiety
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any eligibility criteria for participation in this clinical experiment?
"This clinical trial is currently accepting 350 participants who are between 18 and 41 years old, as well as clinically diagnosed with depression."
Does this research endeavor have an age restriction for participants?
"This research requires participants to be older than 18 years old yet younger than 41."
How many people have registered for this research trial?
"Indeed, the data hosted on clinicaltrials.gov verifies that this medical research is currently recruiting patients. To date, it has been listed since December 15th 2020 and was last updated on September 8th 2022. The investigators intend to enrol a total of 350 individuals across 1 trial site."
What is the desired outcome of this trial?
"This trial has Time to Treatment as its primary outcome, and Recruitment, Attrition, and Improved Health-Related Social Needs as secondary outcomes. The test period spans the duration of pregnancy up until a postpartum year with assessments made at regular intervals throughout this time. Specifically, recruitment is measured by comparing those who agreed to enroll versus total participants solicited while attrition focuses on those that prematurely terminate or cannot be contacted for referral/treatment. Lastly, improved health related social needs are tracked using Accountable Health Communities (AHC) HRSN Screening Tool among LTW patients compared to TAU counterparts."
Are new participants being sought for this experiment?
"Clinicaltrials.gov shows that this trial, which was initially listed on December 15th 2020 is still recruiting individuals. The record of the experiment has been refreshed as recently as September 8th 2022."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger